Zobrazeno 1 - 10
of 16
pro vyhledávání: '"E Ferris Villanueva"'
Autor:
E Ferris Villanueva, S Martín Clavo, M Ferris Villanueva, JF Rangel Mayoral, A Cinza Gonzalez, C Redondo Galán, E Garcia Lobato, MDLOCerezo Arias
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Invasive fungal infections such as Mucormycosis are considered opportunistic infections that occur almost exclusively in immunosuppressed patients, causing high morbidity and mortality. The use of long-term steroids may favour the state of
Autor:
AC Viney, Mdr Gutiérrez Cívicos, D Gutiérrez-Meca Maestre, I Muñoz García, P Conesa Zamora, A García Márquez, R Guerrero Bautista, MH García Lagunar, E Ferris Villanueva, I Español Morales
Publikováno v:
European Journal of Hospital Pharmacy. 23:A191.2-A191
Background Interindividual variability in treatment response may be associated with the presence of gene polymorphisms. Monoclonal antibodies seem to exert, at least partly, their mechanism of action by inducing apoptosis in antigen expressing cells.
Autor:
A García Márquez, E Ferris Villanueva, Mdr Gutiérrez Cívicos, D Lacruz Guzmán, M Martínez Penella, R Guerrero Bautista, I Muñoz García, MH García Lagunar, V Alice Charlotte, AM Chica Marchal
Publikováno v:
European Journal of Hospital Pharmacy. 23:A35.3-A36
Background Oncology patients are susceptible to malnutrition and this is a risk factor for morbidity and mortality. Purpose To evaluate nutritional status in patients treated with oral chemotherapy in a tertiary hospital. Material and methods Prelimi
Autor:
R Guerrero Bautista, D Lacruz Guzman, E Ferris Villanueva, A García Márquez, I Muñoz García, A Charlotte Viney, MS García Simón, M Martínez Penella, MC Mira Sirvent
Publikováno v:
European Journal of Hospital Pharmacy. 23:A23.2-A23
Background Since 1981, the year of the first case of infection with HIV/AIDS, about 60 million people have been infected with the virus, and some 20 million have died. But since the appearance in 1995 of the so-called highly active antiretroviral the
Autor:
A García Márquez, E Ferris Villanueva, AC Viney, R Guerrero Bautista, Mdr Gutiérrez Cívicos, A De Béjar Almira, C Fuentes Gutiérrez, MH García Lagunar, AM Chica Marchal, I Muñoz García
Publikováno v:
European Journal of Hospital Pharmacy. 23:A38.1-A38
Background Palivizumab is a monoclonal antibody that provides passive immunity against respiratory syncytial virus (RSV) and has very specific criteria for use that have changed recently. According to the literature data, the annual incidence of bron
Autor:
I Muñoz García, MH García Lagunar, Gutiérrez Cívicos, A García Márquez, E Ferris Villanueva, R Guerrero Bautista, M Martínez Penella
Publikováno v:
European Journal of Hospital Pharmacy. 22:A119.2-A119
Background The lack of studies published on stability of antineoplastic drugs and the contradictory character of the information available increased the need to carry out an internal review in our hospital. Purpose To investigate the physical-chemica
Autor:
A García Márquez, García Simón, M Gutiérrez Cívicos, D Lacruz Guzmán, R Guerrero Bautista, Álvarez Álvarez, I Muñoz García, MH García Lagunar, M Martínez Penella, E Ferris Villanueva
Publikováno v:
European Journal of Hospital Pharmacy. 22:A13.1-A13
Background Behcet’s disease (BD) is a rheumatic disease characterised by polyarthritis, urogenital ulcers, uveitis, cutaneous lesions, alterations in the central nervous system and vascular disease. Purpose To describe the use of adalimumab in a pa
Autor:
R Guerrero Bautista, AM Chica Marchal, MH García Lagunar, García Simón, A García Márquez, I Muñoz García, M Martínez Penella, Mdr Gutiérrez Cívicos, E Ferris Villanueva, D Lacruz Guzmán
Publikováno v:
European Journal of Hospital Pharmacy. 22:A13.2-A14
Background The use of drugs during pregnancy is always controversial. There is limited information about the use of infliximab during pregnancy. Purpose To describe the effectiveness and safety of infliximab in a patient with ankylosing spondylitis d
Autor:
E Ferris Villanueva, A García Márquez, M Gutiérrez Cívicos, I Español Morales, MH García Lagunar, D Lacruz Guzmán, R Guerrero Bautista, M Martínez Penella, I Muñoz García, García Simón
Publikováno v:
European Journal of Hospital Pharmacy. 22:A32.1-A32
Background Idiopathic thrombocytopenic purpura (ITP) is a disease characterised by decreased platelet count. Romiplostim and eltrombopag are thrombopoietin receptor agonists (TRAs) that stimulate platelet production. Purpose To evaluate the effective
Autor:
R Guerrero Bautista, A García Márquez, Gutiérrez Cívicos, I Muñoz García, MH García Lagunar, I Español Morales, P Conesa Zamora, M Martínez Penella, D Gutiérrez-Meca Maestre, E Ferris Villanueva
Publikováno v:
European Journal of Hospital Pharmacy. 22:A137.1-A137
Background The interindividual variability in drug response and toxicity is well known and may be related to genetic factors. TRAIL and TRAILR1 are proteins involved in the induction of apoptosis by the extrinsic pathway and may be implicated in the